Inflammatory Bowel Disease and Thromboembolic Events

Centro Hospitalar Tondela-Viseu

Status: Completed

Conditions: Thromboembolism; Coagulation Disorder; Inflammatory Bowel Diseases

Treatments: Other: No intervention was made

Study type: Observational

Funder types: Other

Identifiers

NCT05162339

CHTV07/2020.1

Details and patient eligibility

About

The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.

Enrollment: 149 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with 18 years of age or older, diagnosed with IBD, followed at a gastroenterology consultation at Centro Hospitalar Tondela-Viseu, between November 2016 and April 2017.

Exclusion criteria

• Individuals with other risk factors for TE (severe hepatic or renal failure, valvular heart disease, atrial fibrillation, heart failure or cardiomyopathy, pregnancy, and oral anticoagulants or heparin at the baseline).

Trial design

149 participants in 1 patient group

IBD patients

Treatment:

Other: No intervention was made